Movement Disorders (revue) - Exploration (Accueil)

Index « Keywords » - entrée « Homovanillic Acid (metabolism) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Homovanillic Acid (cerebrospinal fluid) < Homovanillic Acid (metabolism) < Homovanillic acid  Facettes :

List of bibliographic references indexed by Homovanillic Acid (metabolism)

Number of relevant bibliographic references: 7.
Ident.Authors (with country if any)Title
002252 (2009) Diane Doummar [France] ; Fabienne Clot [France] ; Marie Vidailhet [France] ; Alexandra Afenjar [France] ; Alexandra Durr [France] ; Alexis Brice [France] ; Cyril Mignot [France] ; Agnès Guet [France] ; Thierry Billette De Villemeur [France] ; Diana Rodriguez [France]Infantile hypokinetic‐hypotonic syndrome due to two novel mutations of the tyrosine hydroxylase gene
002C43 (2007) Anne M. Landau [Canada] ; Edouard Kouassi [Canada] ; Rosmarie Siegrist-Johnstone [Canada] ; Julie Desbarats [Canada]Proteasome inhibitor model of Parkinson's disease in mice is confounded by neurotoxicity of the ethanol vehicle
005961 (1995) G. K. Wenning [Royaume-Uni] ; M. T. O'Connell [Royaume-Uni] ; P. N. Patsalos [Royaume-Uni] ; Quinn [Royaume-Uni]A clinical and pharmacokinetic case study of an interaction of levodopa and antituberculous therapy in Parkinson's disease
005C02 (1994) S. Rose [Royaume-Uni] ; Jenner [Royaume-Uni] ; C. D. Marsden [Royaume-Uni]Chronic administration does not alter the accumulation of L‐dopa into muscle
005D03 (1993) Muthane [Inde, États-Unis] ; P. Satishchandra [Inde] ; M. N. Subhash [Inde]Visual and auditory evoked potentials in early onset parkinson's disease and their relationship to cerebrospinal fluid monoamine metabolites
005D97 (1993) Baltazar Gomez-Mancilla [Canada, Suisse] ; René Boucher [Canada, Suisse] ; Céline Gagnon [Canada, Suisse] ; Thérèse Di Paolo [Canada, Suisse] ; Rudolf Markstein [Canada, Suisse] ; Bédard [Canada, Suisse]Effect of adding the D1 agonist CY 208–243 to chronic bromocriptine treatment. I: Evaluation of motor parameters in relation to striatal catecholamine content and dopamine receptors
006525 (1988) S. Rose [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; Marsden [Royaume-Uni]The effect of carbidopa on plasma and muscle levels of L‐dopa, dopamine, and their metabolites following L‐dopa administration to rats

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Homovanillic Acid (metabolism)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Homovanillic Acid (metabolism)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Homovanillic Acid (metabolism)
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024